IL-10 Kinetics in Thyroiditis-Prone BB/Wor Rats

References

• Nakhooda A, Like A, Chappel C, Murray F, Marliss E B. The spontaneously diabetic Wistar rat: metabolic and morphologic studies. Diabetes 1977; 26: 100–12
   PubMed Web of Science ®Google Scholar
• Sternthal E, Like A, Sarantis A, Braverman L. Lymphocytic thyroiditis in the BB/W rat. Diabetes 1981; 30: 1058–1061
   PubMed Web of Science ®Google Scholar
• Dyerberg T, Poussier P, Nakhooda A, Marliss E, Lermark A. Humoral immunity in the spontaneously diabetic BB rat. Metabolism 1983; 32: 87–91, Suppll
   PubMed Web of Science ®Google Scholar
• Allen E M, Braverman L E. The BioBreeding Worcester rat -a model of organ-specific autoimmunity. Experimental Clinics of Endocrinolology Diabetes 1996; 104: 7–10, 1996 Suppl 3
   PubMed Web of Science ®Google Scholar
• Rajatanavin R, Appel M C, Reinhardt W, Alex S, Yang Y N, Braverman L E. Variable prevalence of lymphocytic thyroiditis among diabetes-prone sublines of BB/Wor rats. Endocrinology 1991; 128: 153–157
   PubMed Web of Science ®Google Scholar
• Burkart V, Kolb H. Macrophages in islet destruction in autoimmune diabetes mellitus. lmmunobiology 1996; 195: 601–613
   PubMed Web of Science ®Google Scholar
• Kolb-Bachofen V, Schraermeyer U, Hoppe T, Hanenberg H, Kolb H. Diabetes manifestation in BB rats proceeded by pan-pancreatic presence of activated inflammatory macrophages. Pancreas 1992; 7: 578–584
   PubMed Web of Science ®Google Scholar
• Simons P J, Delemarre F GA, Jeucken P HM, Drexhage H A. Pre-autoimmune thyroid abnormalities in the BioBreeding diabetes-prone (BB-DP) rat: a possible relation with the intrathyroid accumulation of dendritic cells and the initiation of the thyroid autoimmune response. Journal of Endocrinology 1998; 157: 43–5
   PubMed Web of Science ®Google Scholar
• Tafuri A, Bowers W E, Handler E S, Appel M, Lew R, Greiner D, Mordes J P, Rossini A A. High stimulatory activity of dendritic cells from diabetes-prone BioBreeding Worcester rats exposed to macrophage-derived factors. Journal of Clinical Investation 1993; 91: 2040–2048
   PubMed Web of Science ®Google Scholar
• Lee K U. Nitric oxide produced by macrophages mediates suppression of Con A-induced proliferative responses of splenic leukocytes in the diabetes-prone BB rat. Diabetes 1994; 43: 1218–20
   PubMed Web of Science ®Google Scholar
• Lau A, Ramanathan S, Poussier P. Excessive production of nitric oxide by macrophages from DP-BB rats is secondary to the T-lymphopenic state of these animals. Diabetes 1998; 47: 197–205
   PubMed Web of Science ®Google Scholar
• Chung Y H, Jun H S, Kang Y, Hirasawa K, Lee B R, Rooijen N V, Yoon J W. Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats. Journal of Immunology 1997; 159: 466–471
   PubMed Web of Science ®Google Scholar
• Scott J. The spontaneously-diabetic BB rat: Sites of the defects leading to autoimmunity and diabetes mellitus. A review. Current Topics in Microbiology and Immunology 1990; 156: 1–14
   PubMed Web of Science ®Google Scholar
• Bellgrau D, Naji A, Silvers W, Markmann J, Barker C. Spontaneous diabetes in BB rats: evidence for T cell dependent immune response defect. Diahetologia 1982; 23: 359–64
   PubMed Web of Science ®Google Scholar
• Elder M E, Maclaren N K. Identification of profound peripheral T-lymphocyte deficiencies in the spontaneously diabetic BB rat. Journal of Immunology 1983; 130: 1723–31
   PubMed Web of Science ®Google Scholar
• Woda B A, Padden C. Mitogen responsiveness of lymphocytes from the BB/W rat. Diabetes 1985; 35: 513–16
   Web of Science ®Google Scholar
• Kimura H, Davies T F. Thyroid-specific T cells in the Wistar rat: Induction of anergy by a syngeneic thyroid cell line. Autoimmunity 1996; 24: 47–53
   PubMed Web of Science ®Google Scholar
• Sellins K S, Gold D P, Bellgrau D. Resistance to tolerance induction in the diabetes-prone BioBreeding rat as one manifestation of abnormal responses to superantigens. Diahetologia 1996; 39: 28–36
   PubMed Web of Science ®Google Scholar
• Georgiou H, Lagarde A C, Bellgrau D. T cell dysfunction in the diabetes-prone BB rat: a role for thymic migrants that are not T cell precursors. Journal of Experimental Medicine 1988; 167: 132–418
   PubMed Web of Science ®Google Scholar
• Rozing J, Coolen C, Tielen F J, Weegener J, Schuurman H J, Greiner D L, Rossini A A. Defects in thymic epithelial stroma of diabetes prone BB rats. Thymus 1989; 14: 125–135
   PubMedGoogle Scholar
• Fox C. J., Danska J S. Independent genetic regulation of T cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 1998; 47: 331–338
   PubMed Web of Science ®Google Scholar
• Piganelli J. D., Martin T, Haskins K. Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 1998; 47: 1212–1218
   PubMed Web of Science ®Google Scholar
• Bottomly K. T cells and dendritic cells get intimate. Science 1999; 283: 124–125
   Web of Science ®Google Scholar
• Rissoan M C, Soumelis V, Kadowaki N, Gourd G, Briere F, de Waal Malefyt R, Liu Y J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183–1; 186
   PubMed Web of Science ®Google Scholar
• Mosman T R. Properties and functions of Interleukin-10. Advances in Immunology 1994; 56: 1–26
   PubMed Web of Science ®Google Scholar
• de Vries J E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Annals of Medicine 1995; 27: 537–541
   PubMed Web of Science ®Google Scholar
• Lalani I, Bohl K, Ahmed R. Interleukin-10: biology, role in inflammation and autoimmunity. Annals of Allergy Asthma and Immunology 1997; 79: 469–484
   PubMed Web of Science ®Google Scholar
• Balasa B, Sarvetnick N. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. Journal of Autoimmunity 1996; 9: 283–286
   PubMed Web of Science ®Google Scholar
• Rosenbaum J T, Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. Journal of lmmunology 1995; 155: 4090–4094
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorofortn extraction. Analytical Biochemistry 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Zipris D, Greiner D L, Malkani S, Whalen B, Mordes J P, Rossini A A. Cytokine gene expression in islet and thyroids of BB rats. Journal of Immunology 1992; 148: 2217–22
   PubMed Web of Science ®Google Scholar
• Allen E M, Thupari J N. Thyroglobulin-reactive T lymphocytes in thyroiditis-prone BBAVor rats. Journal of Endocrinological Investigations 1995; 18: 45–49
   PubMed Web of Science ®Google Scholar
• Jander S, Pohl J, Gillen C, Stoll G. Differential expression of interleukin 10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. Journal of Neuroscience Research 1996; 43: 254–259
   PubMed Web of Science ®Google Scholar
• Jander S, Pohl J, D'Urso D, Gillen C, Stoll G. Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. American Journal of Pathology 1998; 152: 975–982
   PubMed Web of Science ®Google Scholar
• Gallagher K T, Bernstein B. Juvenile rheumatoid arthritis. Current Opinions in Rheumatology 1999; 11: 372–376
   PubMedGoogle Scholar
• Lu L, Lee W C, Takayama T, Qian S., Gambotto A., Robbins P D, Thomson A W. Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA41g). Journal of Leukocyte Biology 1999; 66: 293–296
   PubMed Web of Science ®Google Scholar
• Salazar-Onfray F. Interleukin-10: a cytokine used by tumors to escape immunosurveillance. Medical Oncology 1999; 16: 86–94
   PubMed Web of Science ®Google Scholar
• Huhn R D, Pennline K, Radwanski E, Clarke L, Sabo R, Cutler D L. Effects of single intravenous doses of recombinant human interferon-10 on subsets of circulating leukocytes in humans. Immunopharmacology 1999; 41: 109–117
   PubMed Web of Science ®Google Scholar
• Sands B E. Novel therapies for inflammatory bowel disease. Gastroenterology Clinics of North America 1999; 28: 323–51
   PubMed Web of Science ®Google Scholar
• Zhang W., Kong Y C. Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis. Cellular Immunology 1998; 187: 95–102
   PubMed Web of Science ®Google Scholar
• Bettelli E, Pradhu Das M, Howard E D, Wiener H L, Sobel R A, Kuchroo V K. IL-10 is critical in the regulation of autoimmune encephalitis as demonstrated by studies of 1L-10 and IL-4 deficient transgenic mice. Journal of Immunology 1998; 161: 3299–3306
   PubMed Web of Science ®Google Scholar
• Batteux F, Trebeden H, Charriere J, Chiocchia G. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. European Journal of Immunology 1999; 29: 958–63
   PubMed Web of Science ®Google Scholar
• Pennline K J, Rogue-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in nonobese diabetic mouse. Clinical Immunology and Immunopathology 1994; 71: 169–175
   PubMedGoogle Scholar
• Wogensen L, Lee M S, Sarvetnick N. Production of Interleukin 10 by islet cells accelerates immune-mediated destruction of cells in nonobese diabetic mice. Journal of Experimantal Medicine 1994; 179: 1379–1384
   PubMed Web of Science ®Google Scholar
• Wogensen L, Huang X, Sarvetnick N. Leukocyte extravaga-tion into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of langerhans. Journal of Experimental Medicine 1993; 178: 175–185
   PubMed Web of Science ®Google Scholar
• Lee M S, Wicker L S, Peterson L B, Sarvetnick N. Pancreatic IL-10 induces diabetes in NOD. B6 Idd31ddl10 mice. Autoimmunity 1997; 26: 215–221
   PubMed Web of Science ®Google Scholar
• Pauza M E, Neal H, Hagenbaugh A, Cheroutre H. LoT-cell production of an inducibleinterleukin-10 transgene provides limited protection from autoimmune disease. Diabetes 1999; 48: 1948–1953
   PubMed Web of Science ®Google Scholar
• Ajjan R A, Watson P F, McIntosh R S, Weetman A P. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clinical and Experimental Immunology 1996; 105: 523–528
   PubMed Web of Science ®Google Scholar
• De la Vega J R, Vilaplana J C, Biro A, Hammond L, Bottazzo G F, Mirakian R. IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity?. Clinical and Experimental Immunology 1998; 113: 126–135
   PubMed Web of Science ®Google Scholar
• Heure M, Aust G, Ode-Hakim S, Scherbaum W A. Different cytokine mRNA profiles in Graves' Disease, Hashimoto's thyroiditis and nonautoimmune thyroid disorders by quantitative reverse transcriptase polymerase chain reaction. 77iy-roid 1996; 6: 97–106
   Google Scholar
• Paschke R, Schuppert F, Taton M, Velu T. Intrathyroidal cytokine gene expression in autoimmune thyroiditis. Journal of Endocrinology 1994; 141: 309–315
   PubMed Web of Science ®Google Scholar
• Maldonado-Lopez R, De Smedt T, Pajak B, et al. Role of CD8a+ and CD8cc dendritic cells in the induction of primary immune responses in vivo. Journal of Leukocyte Biology 1999; 66: 242–246
   PubMed Web of Science ®Google Scholar
• Paolieri F, Salmaso C, Batdfora M, et al. Possible pathogenic relevance of Interleukin-1 beta in “destructive” organ-specific autoimmune disease (Hashimoto's thyroiditis. Annals of the New York Academy of Science 1999; 876: 221–228
   PubMed Web of Science ®Google Scholar